PDCD1LG2 and neoplasm: PD-L1 expression, but not PD-L2, is correlated to significantly poorer survival than the ligand-negative patients, and it is inversely correlated with tumor-infiltrating lymphocytes within the tumor, particularly CD8+ T cells [105].